CHRIS MICHAEL DONAGHE
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Psychiatric/Mental Health REDDING, CA NPI 1356096739
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Psychiatric/Mental Health CA Neurocrine BioSciences, Inc. All categories
General Payments — all program years on this page
$684.22
- Category: General Payments
- Program years: PY2022–2024
- Record count: 16
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $168.14 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $168.14 | 7 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Neurocrine BioSciences, Inc. | $55.50 | 2 |
| Indivior Inc. | $47.38 | 2 |
| Teva Pharmaceuticals USA, Inc. | $27.59 | 1 |
| ITI, Inc. | $20.18 | 1 |
| Janssen Pharmaceuticals, Inc | $17.49 | 1 |
By program year
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1077935772 | Janssen Pharmaceuticals, Inc | $17.49 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1143431217 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $20.18 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1144550245 | Indivior Inc. | $23.30 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1144550247 | Indivior Inc. | $24.08 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1150943507 | Neurocrine Biosciences, Inc. | $28.56 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1150948079 | Neurocrine Biosciences, Inc. | $26.94 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1151465641 | Teva Pharmaceuticals USA, Inc. | $27.59 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.